Related Experiment Videos
Nicotine blocks quinpirole-induced behavior in rats: psychiatric implications
Y Tizabi1, R L Copeland, R Brus
1Department of Pharmacology, College of Medicine, Howard University, 520W Street N.W., Washington, DC 20059, USA. ytizabi@howard.edu
Psychopharmacology
|August 25, 1999
Summary
Dopamine D2/D3 agonist treatment in rats alters nicotinic receptors, suggesting nicotine may help treat disorders linked to dopamine imbalance. This research explores neurochemical system interactions.
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- Dopaminergic and nicotinic cholinergic systems play roles in neurological and neuropsychiatric disorders.
- Understanding their intermodulation is crucial for therapeutic development.
Purpose of the Study:
- To investigate the intermodulatory roles of dopaminergic and nicotinic cholinergic systems.
- To assess how dopamine D2/D3 agonist treatment affects nicotinic receptors and behavior.
Main Methods:
- Rats were treated with the dopamine D2/D3 agonist quinpirole (QNP) during early development.
- Behavioral sensitization (hyperlocomotion, yawning) was assessed.
- Nicotine and mecamylamine (nicotinic antagonist) effects were evaluated.
- Neurotransmitter receptor binding ([3H]cytisine and [125I]alpha-bungarotoxin) was measured.
Main Results:
- QNP-induced behavioral sensitization was partially or totally blocked by nicotine.
- Nicotine's effects were partially or totally blocked by mecamylamine.
- QNP-primed rats showed altered nicotinic receptor binding in the midbrain, cerebellum, hippocampus, and striatum.
Conclusions:
- Dopamine D2/D3 agonist treatment alters nicotinic alpha4beta2 and alpha7 receptors.
- Nicotinic agonists may offer therapeutic benefits for disorders involving central dopaminergic imbalance.